Published in Neurogenetics on March 09, 2006
Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a/b: linking growth hormone to the androgen receptor. FASEB J (2009) 1.00
Excitation-contraction coupling alterations in mdx and utrophin/dystrophin double knockout mice: a comparative study. Am J Physiol Cell Physiol (2010) 0.98
Finding consistent disease subnetworks across microarray datasets. BMC Bioinformatics (2011) 0.95
Sustaining cardiac claudin-5 levels prevents functional hallmarks of cardiomyopathy in a muscular dystrophy mouse model. Mol Ther (2012) 0.85
Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice. Hum Mol Genet (2011) 0.84
Metabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophy. PLoS One (2015) 0.82
Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target. FASEB J (2015) 0.80
Disease course in mdx:utrophin+/- mice: comparison of three mouse models of Duchenne muscular dystrophy. Physiol Rep (2015) 0.78
Functional characterization of orbicularis oculi and extraocular muscles. J Gen Physiol (2016) 0.75
Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74
The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell (1988) 10.75
The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science (1989) 6.80
Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature (1986) 6.45
Myogenic satellite cells: physiology to molecular biology. J Appl Physiol (1985) (2001) 6.27
Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell (1997) 4.38
Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature (1990) 4.23
Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell (1997) 3.68
Developmental regulation of myosin gene expression in mouse cardiac muscle. J Cell Biol (1990) 3.54
Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell (1995) 3.53
Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med (1998) 3.27
A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet (2002) 2.80
Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature (1992) 2.76
The structural and functional diversity of dystrophin. Nat Genet (1993) 2.43
Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res (1991) 2.34
Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J (2005) 2.07
Transitions of muscle fiber phenotypic profiles. Histochem Cell Biol (2001) 1.89
Forced expression of dystrophin deletion constructs reveals structure-function correlations. J Cell Biol (1996) 1.79
Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells. J Cell Physiol (1994) 1.72
Biological organization of the extraocular muscles. Prog Brain Res (2006) 1.69
Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem (1995) 1.67
A new model for the interaction of dystrophin with F-actin. J Cell Biol (1996) 1.66
Remodeling of cell-cell and cell-extracellular matrix interactions at the border zone of rat myocardial infarcts. Circ Res (1999) 1.55
Myosin light chain-2 luciferase transgenic mice reveal distinct regulatory programs for cardiac and skeletal muscle-specific expression of a single contractile protein gene. J Biol Chem (1992) 1.49
Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nat Med (1997) 1.43
Analysis of the actin-binding domain of alpha-actinin by mutagenesis and demonstration that dystrophin contains a functionally homologous domain. J Cell Biol (1992) 1.43
Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur J Biochem (1994) 1.38
Structure and function of the neuromuscular junction in young adult mdx mice. J Neurocytol (1991) 1.36
Expression of the N-terminal domain of dystrophin in E. coli and demonstration of binding to F-actin. FEBS Lett (1992) 1.36
Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol (1997) 1.33
Myosin storage myopathy associated with a heterozygous missense mutation in MYH7. Ann Neurol (2003) 1.29
Dystrophin and utrophin influence fiber type composition and post-synaptic membrane structure. Hum Mol Genet (2000) 1.18
Increasing complexity of the dystrophin-associated protein complex. Proc Natl Acad Sci U S A (1994) 1.18
Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Hum Mol Genet (2003) 1.17
Force: velocity properties of mouse muscles. Nature (1965) 1.17
Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. J Cell Sci (1994) 1.13
Different distributions of dystrophin and related proteins at nerve-muscle junctions. Neuroreport (1992) 1.10
Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Hum Mol Genet (2003) 1.09
Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse. Neuromuscul Disord (1998) 1.08
The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. J Cell Sci (1998) 1.06
Expression of rabbit ventricular alpha-myosin heavy chain messenger RNA sequences in atrial muscle. J Biol Chem (1984) 1.01
Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Mol Med (Berl) (2005) 1.01
Expression of dystrophin-associated proteins in dystrophin-positive muscle fibers (revertants) in Duchenne muscular dystrophy. Neuromuscul Disord (1994) 0.98
Neuromuscular transmission in the mdx mouse. Muscle Nerve (1990) 0.90
Structural changes in the early stages of Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry (1972) 0.87
CASK and Dlg form a PDZ protein complex at the mammalian neuromuscular junction. Muscle Nerve (2004) 0.83
Localization of the dystrophin binding site at the carboxyl terminus of beta-dystroglycan. Biochem Biophys Res Commun (1996) 0.83
Effect of muscle origin and phenotype on satellite cell muscle-specific gene expression. J Mol Cell Cardiol (2003) 0.80
Histochemical fibre "types" in Duchenne muscular dystrophy. J Neurol Sci (1970) 0.77
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest (2007) 2.99
A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet (2002) 2.80
Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell (2005) 2.73
FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol (2005) 2.31
miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ Res (2009) 1.91
Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest Ophthalmol Vis Sci (2007) 1.90
Can social capital be intentionally generated? a randomized trial from rural South Africa. Soc Sci Med (2008) 1.69
Biological organization of the extraocular muscles. Prog Brain Res (2006) 1.69
Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle. Proc Natl Acad Sci U S A (2006) 1.68
Is social capital associated with HIV risk in rural South Africa? Soc Sci Med (2008) 1.66
Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol (2005) 1.53
Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. J Biol Chem (2004) 1.47
Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging (2011) 1.47
Claudin-5 levels are reduced in human end-stage cardiomyopathy. J Mol Cell Cardiol (2008) 1.34
Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. Physiol Genomics (2006) 1.31
Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice. J Neurol Sci (2007) 1.31
Claudin-5 localizes to the lateral membranes of cardiomyocytes and is altered in utrophin/dystrophin-deficient cardiomyopathic mice. J Mol Cell Cardiol (2005) 1.28
Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice. Neuromuscul Disord (2005) 1.27
Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle. Neuromuscul Disord (2003) 1.19
Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics. Oncogene (2002) 1.18
Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Hum Mol Genet (2003) 1.17
Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy. Mol Med (2011) 1.09
Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Hum Mol Genet (2003) 1.09
Proteolytic cleavage of cyclin E leads to inactivation of associated kinase activity and amplification of apoptosis in hematopoietic cells. Mol Cell Biol (2002) 1.05
Impairment of diastolic function by lack of frequency-dependent myofilament desensitization rabbit right ventricular hypertrophy. Circ Heart Fail (2009) 1.03
Challenges in drug development for muscle disease: a stakeholders' meeting. Muscle Nerve (2007) 1.02
Novel complement inhibitor limits severity of experimentally myasthenia gravis. Ann Neurol (2009) 1.01
Genome-wide transcriptional profiles are consistent with functional specialization of the extraocular muscle layers. Invest Ophthalmol Vis Sci (2004) 1.01
Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice. FASEB J (2003) 1.00
Economic evaluation of a combined microfinance and gender training intervention for the prevention of intimate partner violence in rural South Africa. Health Policy Plan (2010) 0.99
Transcriptional profile of rat extraocular muscle by serial analysis of gene expression. Invest Ophthalmol Vis Sci (2002) 0.99
Distinctive morphological and gene/protein expression signatures during myogenesis in novel cell lines from extraocular and hindlimb muscle. Physiol Genomics (2005) 0.98
Anti-C5 antibody treatment ameliorates weakness in experimentally acquired myasthenia gravis. J Immunol (2007) 0.97
Conserved and muscle-group-specific gene expression patterns shape postnatal development of the novel extraocular muscle phenotype. Physiol Genomics (2004) 0.95
Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment? Ann N Y Acad Sci (2008) 0.92
Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy. J Transl Med (2011) 0.90
The development of longitudinal variation of Myosin isoforms in the orbital fibers of extraocular muscles of rats. Invest Ophthalmol Vis Sci (2004) 0.88
Comprehensive expression profiling by muscle tissue class and identification of the molecular niche of extraocular muscle. FASEB J (2003) 0.88
The force-temperature relationship in healthy and dystrophic mouse diaphragm; implications for translational study design. Front Physiol (2012) 0.88
Cilostazol protects diabetic rats from vascular inflammation via nuclear factor-kappa B-dependent down-regulation of vascular cell adhesion molecule-1 expression. J Pharmacol Exp Ther (2006) 0.87
Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases. Neuromuscul Disord (2012) 0.87
Peroxisome proliferator-activated receptor-alpha regulates the expression of pancreatic/duodenal homeobox-1 in rat insulinoma (INS-1) cells and ameliorates glucose-induced insulin secretion impaired by palmitate. Endocrinology (2007) 0.86
Comprehensive evaluation of the extraocular muscle critical period by expression profiling in the dark-reared rat and monocularly deprived monkey. Invest Ophthalmol Vis Sci (2003) 0.86
Paradoxical absence of M lines and downregulation of creatine kinase in mouse extraocular muscle. J Appl Physiol (1985) (2003) 0.86
Postnatal suppression of myomesin, muscle creatine kinase and the M-line in rat extraocular muscle. J Exp Biol (2003) 0.86
Chronically elevated glucose-induced apoptosis is mediated by inactivation of Akt in cultured Müller cells. Biochem Biophys Res Commun (2005) 0.86
Sustaining cardiac claudin-5 levels prevents functional hallmarks of cardiomyopathy in a muscular dystrophy mouse model. Mol Ther (2012) 0.85
Molecular organization of the extraocular muscle neuromuscular junction: partial conservation of and divergence from the skeletal muscle prototype. Invest Ophthalmol Vis Sci (2003) 0.85
Glutamate receptors localize postsynaptically at neuromuscular junctions in mice. Muscle Nerve (2009) 0.84
CASK and Dlg form a PDZ protein complex at the mammalian neuromuscular junction. Muscle Nerve (2004) 0.83
Tissue-specific expression of PPAR mRNAs in diabetic rats and divergent effects of cilostazol. Can J Physiol Pharmacol (2008) 0.83
Lengthening-contractions in isolated myocardium impact force development and worsen cardiac contractile function in the mdx mouse model of muscular dystrophy. J Appl Physiol (1985) (2010) 0.82
Chronic palmitate exposure inhibits AMPKalpha and decreases glucose-stimulated insulin secretion from beta-cells: modulation by fenofibrate. Acta Pharmacol Sin (2008) 0.81
Phosphatidylinositol 3-kinase/nuclear factor-kappa B signaling pathway is involved in the regulation of IGF-I on Fas-associated death domain-like interleukin-1-converting enzyme-inhibitory protein expression in cultured FRTL thyroid cells. J Mol Endocrinol (2007) 0.80
CASK localizes to nuclei in developing skeletal muscle and motor neuron culture models and is agrin-independent. J Cell Physiol (2006) 0.79
Conservation of synapse-signaling pathways at the extraocular muscle neuromuscular junction. Ann N Y Acad Sci (2002) 0.78
Genomic profiling reveals Pitx2 controls expression of mature extraocular muscle contraction-related genes. Invest Ophthalmol Vis Sci (2012) 0.78
The glutathione-dependent system of antioxidant defense is not modulated by temperature acclimation in muscle tissues from striped bass, Morone saxatilis. Comp Biochem Physiol A Mol Integr Physiol (2012) 0.78
Monocular visual deprivation in macaque monkeys: a profile in the gene expression of lateral geniculate nucleus by laser capture microdissection. Mol Vis (2008) 0.76
Perspectives on best practices for gene therapy programs. Hum Gene Ther (2015) 0.76
Somatic gene therapy to treat heart failure is one step closer to reality. Cardiovasc Res (2009) 0.75
Extraocular muscle gene expression and function after dark rearing. Ann N Y Acad Sci (2002) 0.75
Adding more muscle and nerve to clinical trials. Muscle Nerve (2011) 0.75
Hyperoxia Does Not Extend Critical Thermal Maxima (CTmax) in White- or Red-Blooded Antarctic Notothenioid Fishes. Physiol Biochem Zool (2015) 0.75
Truncated CASK does not alter skeletal muscle or protein interactors. Muscle Nerve (2008) 0.75